People with squamous cell cancer in trial planning
Part of Cancer clinical trials.
This study looks at patient experiences and perspectives while people receive care in clinical trials for squamous cell carcinoma. It may help improve how future trials are run and supported for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have a confirmed diagnosis of squamous cell carcinoma
- Be willing and able to follow the study plan (treatments, checkups, and exams) for the full study period
- Be able to give written informed consent (sign permission)
- Not be pregnant, breastfeeding, or planning to conceive during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device placed on skin cancer lesions to see which drugs might work best. It is for people with visible squamous cell carcinoma on the skin, including lesions that have come back after radiation.
This trial collects tumor samples from people with head and neck squamous cell cancer to study why some cancers stop responding to standard treatments like cetuximab. The goal is to learn how resistance develops so better therapies can be found.
This study follows patients newly diagnosed with cutaneous squamous cell carcinoma (a type of skin cancer) who are beginning systemic treatment (medicine that affects the whole body). Researchers want to understand how these treatments work and track patient outcomes over time.
This study looks at how doctors stage (classify the extent of) a type of skin cancer called cutaneous squamous cell carcinoma. You may be helping researchers by allowing your clinical data to be used for research.
This early-phase study tests whether combining an injection into the skin lesion with a topical cream can treat squamous cell skin cancer. It may help shrink the cancer and improve control in people whose tumor is in the lower legs or feet.
This study tests an optimized plan for treating squamous cell cancer in the head and neck area using curative treatment that includes chemotherapy with cisplatin plus radiation after surgery. It may help doctors improve early management and outcomes for people eligible for this standard approach.
Hear when a new Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.